Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Feb;50(2):128–134. doi: 10.1136/jcp.50.2.128

Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.

D Wright 1, P McKeever 1, R Carter 1
PMCID: PMC499737  PMID: 9155693

Abstract

AIM: To review the presenting clinical features and the histology of cases of non-Hodgkin lymphoma (NHL) entered into the United Kingdom Children's Cancer Study Group NHL Trial. METHODS: Sections of biopsy specimens from all cases entered into the trial were stained with Giemsa and haematoxylin and eosin. All cases were stained immunohistochemically for CD45, CD3, CD45RO, CD20, and CD30. Sections were stained with either naphthol AS-D chloroacetate esterase or KP1 (CD68) to identify granulocytic tumours. In a minority of cases, additional immunohistochemical stains were performed when necessary to establish the diagnosis. The sections were reviewed by three pathologists. RESULTS: Of 308 cases analysed, 293 were categorised as NHL. There was only one case of low grade lymphoma in the series. Over 80% of the cases fell into the categories Burkitt lymphoma (42.2%), lymphoblastic lymphoma (27.2%) and anaplastic large cell lymphoma (15.1%). Cases of Burkitt lymphoma presented most often with abdominal tumours mainly of the ileocaecal region. Tumours of the oropharynx and nasopharynx were also common in this group. Of the 84 lymphoblastic lymphomas, 56 were of the T-cell phenotype, 12 of the B-cell phenotype and 16 of indeterminate lineage. Most of the T-lymphoblastic lymphomas showed mediastinal or pleural involvement. Infiltration of the skin and soft tissues was seen in 25% of lymphoblastic lymphoma of B or indeterminate phenotype. Forty six children were diagnosed as having anaplastic large cell lymphoma, the majority being of T or indeterminate lineage. Most patients presented with lymphadenopathy but involvement of the bones, soft tissues or skin was seen in seven patients and of the mediastinum and lungs in five. CONCLUSION: Childhood non-Hodgkin lymphomas are almost all high grade and frequently extranodal. They fall mainly into the categories Burkitt lymphoma, lymphoblastic lymphoma and anaplastic large cell lymphoma. The separation of these subcategories can be made on the basis of morphology and immunohistochemical features. The anatomical distribution of these different categories of non-Hodgkin lymphoma is distinctive.

Full text

PDF
134

Images in this article

129Image
on p.129
129Image
on p.129
130Image
on p.130
130Image
on p.130
130Image
on p.130
131Image
on p.131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  2. Bernard A., Murphy S. B., Melvin S., Bowman W. P., Caillaud J., Lemerle J., Boumsell L. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood. 1982 Mar;59(3):549–554. [PubMed] [Google Scholar]
  3. Bitter M. A., Franklin W. A., Larson R. A., McKeithan T. W., Rubin C. M., Le Beau M. M., Stephens J. K., Vardiman J. W. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol. 1990 Apr;14(4):305–316. doi: 10.1097/00000478-199004000-00001. [DOI] [PubMed] [Google Scholar]
  4. Cossman J., Chused T. M., Fisher R. I., Magrath I., Bollum F., Jaffe E. S. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res. 1983 Sep;43(9):4486–4490. [PubMed] [Google Scholar]
  5. Delsol G., Al Saati T., Gatter K. C., Gerdes J., Schwarting R., Caveriviere P., Rigal-Huguet F., Robert A., Stein H., Mason D. Y. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol. 1988 Jan;130(1):59–70. [PMC free article] [PubMed] [Google Scholar]
  6. Falini B., Pileri S., Stein H., Dieneman D., Dallenbach F., Delsol G., Minelli O., Poggi S., Martelli M. F., Pallesen G. Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies. Hum Pathol. 1990 Jun;21(6):624–629. doi: 10.1016/s0046-8177(96)90009-x. [DOI] [PubMed] [Google Scholar]
  7. Frierson H. F., Jr, Bellafiore F. J., Gaffey M. J., McCary W. S., Innes D. J., Jr, Williams M. E. Cytokeratin in anaplastic large cell lymphoma. Mod Pathol. 1994 Apr;7(3):317–321. [PubMed] [Google Scholar]
  8. Fujimoto J., Hata J., Ishii E., Kiyokawa N., Tanaka S., Morikawa Y., Shimizu K., Hajikano H. Ki-1 lymphomas in childhood: immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker. Virchows Arch A Pathol Anat Histopathol. 1988;412(4):307–314. doi: 10.1007/BF00750256. [DOI] [PubMed] [Google Scholar]
  9. Gustmann C., Altmannsberger M., Osborn M., Griesser H., Feller A. C. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas. Am J Pathol. 1991 Jun;138(6):1413–1422. [PMC free article] [PubMed] [Google Scholar]
  10. Gutiérrez M. I., Bhatia K., Barriga F., Diez B., Muriel F. S., de Andreas M. L., Epelman S., Risueño C., Magrath I. T. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood. 1992 Jun 15;79(12):3261–3266. [PubMed] [Google Scholar]
  11. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  12. Histopathological definition of Burkitt's tumour. Bull World Health Organ. 1969 Apr;40(4):601–607. [PMC free article] [PubMed] [Google Scholar]
  13. Hutchison R. E., Murphy S. B., Fairclough D. L., Shuster J. J., Sullivan M. P., Link M. P., Donaldson S. S., Berard C. W. Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Results from the Pediatric Oncology Group and St. Jude Children's Research Hospital. Cancer. 1989 Jul 1;64(1):23–28. doi: 10.1002/1097-0142(19890701)64:1<23::aid-cncr2820640105>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  14. Le Beau M. M., Bitter M. A., Larson R. A., Doane L. A., Ellis E. D., Franklin W. A., Rubin C. M., Kadin M. E., Vardiman J. W. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia. 1989 Dec;3(12):866–870. [PubMed] [Google Scholar]
  15. Link M. P., Roper M., Dorfman R. F., Crist W. M., Cooper M. D., Levy R. Cutaneous lymphoblastic lymphoma with pre-B markers. Blood. 1983 May;61(5):838–841. [PubMed] [Google Scholar]
  16. Magrath I. T., Sariban E. Clinical features of Burkitt's lymphoma in the USA. IARC Sci Publ. 1985;(60):119–127. [PubMed] [Google Scholar]
  17. Mason D. Y., Bastard C., Rimokh R., Dastugue N., Huret J. L., Kristoffersson U., Magaud J. P., Nezelof C., Tilly H., Vannier J. P. CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol. 1990 Feb;74(2):161–168. doi: 10.1111/j.1365-2141.1990.tb02560.x. [DOI] [PubMed] [Google Scholar]
  18. Mason D. Y., Cordell J. L., Tse A. G., van Dongen J. J., van Noesel C. J., Micklem K., Pulford K. A., Valensi F., Comans-Bitter W. M., Borst J. The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol. 1991 Dec 1;147(11):2474–2482. [PubMed] [Google Scholar]
  19. Morris S. W., Kirstein M. N., Valentine M. B., Dittmer K. G., Shapiro D. N., Saltman D. L., Look A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994 Mar 4;263(5151):1281–1284. doi: 10.1126/science.8122112. [DOI] [PubMed] [Google Scholar]
  20. Neri A., Barriga F., Knowles D. M., Magrath I. T., Dalla-Favera R. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2748–2752. doi: 10.1073/pnas.85.8.2748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Norton A. J., Isaacson P. G. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. Am J Pathol. 1987 Aug;128(2):225–240. [PMC free article] [PubMed] [Google Scholar]
  22. Nowell P. C., Croce C. M. Philip Levine award lecture. Chromosome translocations and oncogenes in human lymphoid tumors. Am J Clin Pathol. 1990 Aug;94(2):229–237. doi: 10.1093/ajcp/94.2.229. [DOI] [PubMed] [Google Scholar]
  23. Orazi A., Cotton J., Cattoretti G., Kotylo P. K., John K., Manning J. T., Neiman R. S. Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections. Am J Clin Pathol. 1994 Nov;102(5):640–645. doi: 10.1093/ajcp/102.5.640. [DOI] [PubMed] [Google Scholar]
  24. Payne C. M., Grogan T. M., Cromey D. W., Bjore C. G., Jr, Kerrigan D. P. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas. Lab Invest. 1987 Aug;57(2):200–218. [PubMed] [Google Scholar]
  25. Pelicci P. G., Knowles D. M., 2nd, Magrath I., Dalla-Favera R. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci U S A. 1986 May;83(9):2984–2988. doi: 10.1073/pnas.83.9.2984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pileri S., Falini B., Delsol G., Stein H., Baglioni P., Poggi S., Martelli M. F., Rivano M. T., Mason D. Y., Stansfeld A. G. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes). Histopathology. 1990 Apr;16(4):383–391. doi: 10.1111/j.1365-2559.1990.tb01143.x. [DOI] [PubMed] [Google Scholar]
  27. Pileri S., Sabattini E., Poggi S., Amini M., Falini B., Stein H. Lymphohistiocytic T-cell lymphoma. Histopathology. 1994 Aug;25(2):191–193. doi: 10.1111/j.1365-2559.1994.tb01583.x. [DOI] [PubMed] [Google Scholar]
  28. Rimokh R., Magaud J. P., Berger F., Samarut J., Coiffier B., Germain D., Mason D. Y. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol. 1989 Jan;71(1):31–36. doi: 10.1111/j.1365-2141.1989.tb06270.x. [DOI] [PubMed] [Google Scholar]
  29. Sandlund J. T., Downing J. R., Crist W. M. Non-Hodgkin's lymphoma in childhood. N Engl J Med. 1996 May 9;334(19):1238–1248. doi: 10.1056/NEJM199605093341906. [DOI] [PubMed] [Google Scholar]
  30. Shiota M., Nakamura S., Ichinohasama R., Abe M., Akagi T., Takeshita M., Mori N., Fujimoto J., Miyauchi J., Mikata A. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood. 1995 Sep 1;86(5):1954–1960. [PubMed] [Google Scholar]
  31. Stansfeld A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelényi G., Sundstrom C., Lennert K., van Unnik J. A., Mioduszewska O. Updated Kiel classification for lymphomas. Lancet. 1988 Feb 6;1(8580):292–293. doi: 10.1016/s0140-6736(88)90367-4. [DOI] [PubMed] [Google Scholar]
  32. Yano T., van Krieken J. H., Magrath I. T., Longo D. L., Jaffe E. S., Raffeld M. Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood. 1992 Mar 1;79(5):1282–1290. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES